86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

26 trials found

diseases per page:

Showing 1 to 10 of 26 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01251848 (ClinicalTrials.gov)	January 2011	1/12/2010	Drug Interaction Between Ritonavir And Sitaxsentan	A Phase 1, Open Label, Randomized, Multiple Dose Study To Assess The Two-Way Drug Interaction Betwee ...	Pulmonary Arterial Hypertension	Drug: Sitaxentan;Drug: Ritonavir;Drug: Sitaxsentan	Pfizer	NULL	Withdrawn	21 Years	55 Years	Both	0	Phase 1	NULL
2	JPRN-JapicCTI-101370	10/12/2010	09/12/2010	Long-Term Open-Label, Safety Study Of SitaxentanSodium In Japanese Pulmonary Arterial Hypertension P ...	A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of SitaxentanSodium In Ja ...	Pulmonary Arterial Hypertension	Intervention name : Sitaxentan sodium INN of the intervention : Sitaxentan Dosage And administration of ...	Pfizer Japan Inc.	NULL		16	80	BOTH	35	Phase 3	NULL
3	NCT01251835 (ClinicalTrials.gov)	December 2010	1/12/2010	Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan	A Phase 1, Open Label, Fixed Sequence Design, Multiple Dose Study To Assess The Effect Of Rifampin O ...	Pulmonary Arterial Hypertension	Drug: Sitaxsentan alone;Drug: Sitaxsentan;Drug: Rifampin	Pfizer	NULL	Withdrawn	21 Years	55 Years	Both	0	Phase 1	NULL
4	NCT01244620 (ClinicalTrials.gov)	November 2010	15/11/2010	A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between SitaxsentanAnd Sildenafil, And Between S ...	A Phase 1, Open Label, Randomized, Four Period, Crossover, Multiple Dose Study To Assess The Pharmac ...	Pulmonary Arterial Hypertension	Drug: sitaxentan;Drug: tadalafil;Drug: sitaxsentan;Drug: sildenafil	Pfizer	NULL	Terminated	21 Years	55 Years	All	16	Phase 1	Singapore
5	NCT01210443 (ClinicalTrials.gov)	November 2010	11/8/2010	Long-Term Open-Label, Safety Study Of SitaxentanSodium In Japanese Pulmonary Arterial Hypertension P ...	A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of SitaxentanSodium In Ja ...	Hypertension, Pulmonary	Drug: Sitaxentan	Pfizer	NULL	Terminated	16 Years	80 Years	All	2	Phase 3	Japan
6	JPRN-JapicCTI-101369	20/8/2010	09/12/2010	A 12 Week Safety And Efficacy Study Of SitaxentanSodium In Japanese Pulmonary Arterial Hypertension ...	A Phase 3, Multi-Center, Open Label Study to Investigate Safety and efficacy of SitaxentanTHERAPY in ...	Pulmonary Arterial Hypertension	Intervention name : Sitaxentan sodium INN of the intervention : Sitaxentan Dosage And administration of ...	Pfizer Japan Inc.	NULL		16	80	BOTH	35	Phase 3	NULL
7	NCT01204853 (ClinicalTrials.gov)	August 2010	6/8/2010	A 12 Week Safety And Efficacy Study Of SitaxentanSodium In Japanese Pulmonary Arterial Hypertension ...	A Phase 3, Multi-Center, Open Label Study To Evaluate The Safety And Efficacy Of SitaxentanSodium In ...	Hypertension, Pulmonary	Drug: Sitaxentan	Pfizer	NULL	Terminated	16 Years	80 Years	All	2	Phase 3	Japan
8	NCT00796510 (ClinicalTrials.gov)	July 2010	20/11/2008	Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjec ...	A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of Monotherapy Sitaxsenta ...	Pulmonary Arterial Hypertension;Pulmonary Hypertension	Drug: Sitaxsentan;Drug: Sitaxsentan and Sildenafil	Pfizer	NULL	Terminated	16 Years	80 Years	All	3	Phase 3	United States;Romania;Ukraine;Argentina;Bulgaria;Chile;China;Colombia;Costa Rica;Czech Republic;Domi ...
9	NCT00995566 (ClinicalTrials.gov)	April 2010	17/9/2009	A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Pre ...	Thelin (SitaxentanSodium) Patient Safety Registry A Non-Interventional, Patient Registry For The Col ...	Pulmonary Arterial Hypertension	Drug: Sitaxentan sodium	Pfizer	NULL	Terminated	18 Years	N/A	All	54	N/A	Belgium;France;Germany;Sweden
10	EUCTR2008-005886-78-CZ (EUCTR)	12/01/2010	10/12/2008	A PHASE 3, MULTI-CENTER, OPEN LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF MONOTHERAPY SITAXSENTA ...	A PHASE 3, MULTI-CENTER, OPEN LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF MONOTHERAPY SITAXSENTA ...	PULMONARY ARTERIAL HYPERTENSION MedDRA version: 9.1;Level: HLT;Classification code 10037401;Term: Pu ...	Trade Name: Thelin INN or Proposed INN: Sitaxsentan Sodium Trade Name: Revatio INN or Proposed INN: Sild ...	Pfizer Ltd.	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Czech Republic;Bulgaria

First Previous1 2 3Next Last